Trial Profile
Studying the Effects of Sibutramine on Eating Behavior.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Sibutramine (Primary)
- Indications Obesity
- Focus Therapeutic Use
- 27 Feb 2012 Actual end date 1 Oct 2010 added as reported by ClinicalTrials.gov.
- 27 Feb 2012 Actual initiation date Feb 2009 and patient number 17 added as reported by ClinicalTrials.gov.
- 27 Feb 2012 Status changed from suspended to discontinued as reported by ClinicalTrials.gov.